Microsatellite instability and TARBP2 mutation study in upper urinary tract urothelial carcinoma.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 23690119.
- Also identified by DOI 10.1309/AJCPBSLP8XHSWLOW.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Microsatellite instability (MSI) contributes to the tumorigenesis of upper urinary tract urothelial carcinomas (UUT-UCs). In this study, we first used MLH1 and MSH2 immunohistochemistry to identify patients with loss of expression of either or both of these proteins in 132 UUT-UCs. We found a total loss of MSH2 expression in 4 patients. MSI was evaluated using 5 markers in these 4 cases. All of the tumors had high MSI (MSI-H) status. Trans-activation responsive RNA-binding protein 2, an integral component of DICER1-containing complex, was a putative target of DNA mismatch repair deficiency. Truncating mutation has been identified in gastrointestinal cancers with MSI. No previous study has evaluated the mutation status of this gene in MSI UUT-UCs. In this study, we analyze the mutation of TARBP2 in MSI-H UUT-UCs with reverse transcription polymerase chain reaction. No truncating mutations were identified in the MSI-H UUT-UCs.
Medical subject headings
- Carcinoma, Transitional Cell
- Kidney Neoplasms
- Microsatellite Instability
- RNA-Binding Proteins
- Ureteral Neoplasms